Saturday, November 21, 2026

#Influenza and Other Respiratory Viruses Research #References (AMEDEO, Nov. 21 '26)

 


    Ann Intern Med

  1. REIS G, Dos Santos Moreira Silva EA, Medeiros Silva DC, Thabane L, et al
    Effect of Fluvoxamine and Metformin for Fatigue in Patients With Long COVID : An Adaptive Randomized Trial.
    Ann Intern Med. 2026 Oct 6. doi: 10.7326/ANNALS-26-02144.
    PubMed         Abstract available


    Epidemiol Infect

  2. CHEN Y, Li J, Luo F, Ling F, et al
    Epidemiology of influenza before, during, and after the COVID-19 pandemic in China: An observational study from Zhejiang, China (2010-2023).
    Epidemiol Infect. 2026 Nov 20:1-14. doi: 10.1017/S0950268826102465.
    PubMed        


    J Infect Dis

  3. YANG Y, Smith M, Ho F, Truscon R, et al
    A prospective, comparative cohort analysis of influenza antibody waning in Michigan and Hong Kong during periods of low influenza circulation.
    J Infect Dis. 2026 Nov 17:jiag559. doi: 10.1093.
    PubMed         Abstract available

  4. HOSSAIN MP, Chen D, Yeung A, Adam DC, et al
    Inferring Diagnostic Serial Intervals to Understand COVID-19 Transmission Dynamics in Hong Kong and Mainland China.
    J Infect Dis. 2026;234:e1236-e1246.
    PubMed         Abstract available

  5. RATU A, Rabukawaqa I, McGregor R, Sassen J, et al
    Neutralisation capacity against SARS-CoV-2 ancestral, Delta and Omicron variants before and after heterologous booster vaccination in Fijian health system workers.
    J Infect Dis. 2026 Jul 17:jiag363. doi: 10.1093.
    PubMed         Abstract available

  6. BORRIELLO F, Koh GCKW, Troconiz IF, Nassirpour R, et al
    Randomized, Double-Blind, Placebo-Controlled First-in-Human Trial of a First-in-Class AI-Designed Monoclonal Antibody (GB-0669) Against the Conserved SARS-CoV-2 Spike S2 Stem Helix.
    J Infect Dis. 2026;234:747-757.
    PubMed         Abstract available


    J Virol

  7. WANG M, Zhao C, Peng R, Bai S, et al
    Structural basis of avian-to-human receptor-binding adaptation in H9Ny influenza A virus hemagglutinin.
    J Virol. 2026 Nov 18:e0151126. doi: 10.1128/jvi.01511.
    PubMed         Abstract available

  8. BARKHYMER AJ, Becker JT, Shepherd FK, Mickelson CK, et al
    A chicken interferon-stimulated gene screen reveals limited genes restricting influenza virus replication.
    J Virol. 2026 Nov 17:e0124326. doi: 10.1128/jvi.01243.
    PubMed         Abstract available

  9. COLARUSSO A, Stephenson KE, Collier A-RY, Wegmann F, et al
    Early innate immune signatures correlate with Ad26.COV2.S vaccine immunogenicity and protective efficacy.
    J Virol. 2026 Oct 26:e0149426. doi: 10.1128/jvi.01494.
    PubMed         Abstract available

  10. ULUSAN S, Markmann AJ, Vanna UP, Castillo I, et al
    Pooled intravenous immunoglobulins exhibit broad binding and Fc-mediated activity against diverse SARS-CoV-2 variants.
    J Virol. 2026 Oct 22:e0147126. doi: 10.1128/jvi.01471.
    PubMed         Abstract available

  11. KEITH AD, Keen MM, Frank F, Lam WA, et al
    Variant escape site mapping and characterization of SARS-CoV-2 nucleocapsid rapid antigen test antibodies.
    J Virol. 2026 Oct 14:e0100126. doi: 10.1128/jvi.01001.
    PubMed         Abstract available

  12. DIONNE K, Belanger E, Benlarbi M, Beaudoin-Bussieres G, et al
    Pre-existing cross-subtype serological responses against H5Nx in health care workers.
    J Virol. 2026;100:e0131026.
    PubMed         Abstract available

  13. LIU Z, Zhang J, Ding Q, Yang C, et al
    Real-time tracking of dual-labeled fluorescent SARS-CoV-2 reveals that the nucleocapsid mutations R203K/G204R accelerate viral uncoating.
    J Virol. 2026 Oct 6:e0108626. doi: 10.1128/jvi.01086.
    PubMed         Abstract available

  14. SILVA MARINHO PE, Ghimire D, Tsai Silva J, Devlin J, et al
    Subtype-specific differences in susceptibility to monoclonal antibodies and vaccines among contemporary RSV-A and RSV-B isolates.
    J Virol. 2026 Oct 5:e0122126. doi: 10.1128/jvi.01221.
    PubMed         Abstract available

  15. LI A, Si H, Wu K, Zhang Q, et al
    Natural variation in BtSARSr-CoV nsp12 harbors adaptive mutations that enhance viral replication and spillover risk in humans.
    J Virol. 2026 Oct 5:e0134326. doi: 10.1128/jvi.01343.
    PubMed         Abstract available


    J Virol Methods

  16. ZHAO M, Qiu P, Wang W, Li Y, et al
    A one-step multiplex real-time reverse transcription quantitative PCR assay for rapid and simultaneous detection of human parainfluenza virus, human metapneumovirus, and rhinovirus in patients with acute respiratory tract infection.
    J Virol Methods. 2026;348:115504.
    PubMed         Abstract available

  17. CAO D, Li J, Zu Y, Wang X, et al
    Development of a quantum dot-based immunochromatographic strip for the rapid detection of H9N2 subtype avian influenza virus.
    J Virol Methods. 2026;348:115503.
    PubMed         Abstract available


    MMWR Morb Mortal Wkly Rep

  18. WINN AK, Anglin O, Anderson EL, Prill MM, et al
    Respiratory Virus Activity - United States, July 2025-June 2026.
    MMWR Morb Mortal Wkly Rep. 2026;75:662-668.
    PubMed         Abstract available


    PLoS Comput Biol

  19. GOLDBERG EE, Kupperman MD, Ke R
    Estimating rates of SARS-CoV-2 lineage spread using graph spectra from genetic sequence data.
    PLoS Comput Biol. 2026;22:e1014920.
    PubMed         Abstract available


    PLoS One

  20. SANDES-FREITAS TV, Requiao-Moura L, Garcia VD, Manfro RC, et al
    Allograft function in kidney transplant recipients following COVID-19.
    PLoS One. 2026;21:e0356034.
    PubMed         Abstract available

  21. SATO S, Matsumoto M, Wakabayashi C, Oki I, et al
    Spatiotemporal analysis of COVID-19 in Japan: The twelve epidemic waves from 2020 to 2025.
    PLoS One. 2026;21:e0363045.
    PubMed         Abstract available

  22. MIGEON A, Laurent E, Chautard R, Desmars H, et al
    Bevacizumab and thrombosis risk in cancer patients with COVID-19: A national retrospective cohort study (TIC-TAC).
    PLoS One. 2026;21:e0362952.
    PubMed         Abstract available

  23. NIESSEN FA, Veldhuijzen IK, Boere TM, Hooiveld M, et al
    Developing a syndromic case definition for timely surveillance of severe acute respiratory infections (SARI) based on financial claim codes in the Netherlands.
    PLoS One. 2026;21:e0338157.
    PubMed         Abstract available

  24. THIT WM, Paek SC, Felix MS, Lamy FR, et al
    Misinformation-based preventive behaviors during the COVID-19 pandemic in Myanmar: A cross-sectional study.
    PLoS One. 2026;21:e0362976.
    PubMed         Abstract available

  25. CUGMAS M, Ferligoj A, Kogovsek T, Batagelj Z, et al
    Social support networks of older adults before, during and after the COVID-19 pandemic.
    PLoS One. 2026;21:e0363274.
    PubMed         Abstract available

  26. CHEN S, Cai M, Song Y, Xu Z, et al
    The global burden of Alzheimer's disease and related dementias: New public health intervention targets driven by the long-term impact of COVID-19 and sex and age differences.
    PLoS One. 2026;21:e0359947.
    PubMed         Abstract available

  27. ASAMNEW A, Shure W, Asres MS, Wondimeneh Y, et al
    Prevalence and associated factors of influenza A virus infection among patients with acute respiratory tract infections in Gondar City, Northwest Ethiopia.
    PLoS One. 2026;21:e0357953.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  28. RICHARDSON BD, Aiello AE, Hudgens MG
    Physical distancing to prevent influenza-like illness on a college campus: The eX-FLU trial.
    Proc Natl Acad Sci U S A. 2026;123:e2626810123.
    PubMed         Abstract available

  29. KIM D, Pasco R, Johnson KE, Fox SJ, et al
    Local influenza forecasts outperform state-level forecasts in the United States.
    Proc Natl Acad Sci U S A. 2026;123:e2616357123.
    PubMed         Abstract available


    Vaccine

  30. CAO Y, Kwan MYW, Murphy C, Chan ELY, et al
    Epidemiology of influenza C in Hong Kong inferred from pediatric hospitalization data.
    Vaccine. 2026;96:129278.
    PubMed         Abstract available


    Virology

  31. WU Y, Yu M, Feng L, Peng Q, et al
    Targeting TMPRSS2 protects against influenza-associated lung injury by suppressing PAR-2/MMP-9 axis.
    Virology. 2026;626:111142.
    PubMed         Abstract available


    Virus Res

  32. OUYANG F, Chen X, Wang M, Huang X, et al
    Serum untargeted metabolomics reveals infection-associated metabolic alterations in chikungunya, dengue, and influenza A virus infections.
    Virus Res. 2026 Nov 17:199832. doi: 10.1016/j.virusres.2026.199832.
    PubMed         Abstract available

  33. UEMURA K, Toba S, Kusakabe S, Sasaki M, et al
    In vivo antiviral efficacy and safety of 5-hydroxymethyltubercidin against DENV2 and SARS-CoV-2.
    Virus Res. 2026;373:199817.
    PubMed         Abstract available

No comments:

Post a Comment

My New Space

Most Popular Posts